Bachem Holding AG
🇬🇧XLON.0QNDUnited KingdomNot reported
Price£81.35-1.55 (-1.87%)
Latest anomalies
Very negative 15 detected in the last 120 days
- High: 5
- Medium: 4
- Low: 6
52-week high: the price is trading close to this level
Volume: a spike above the 20-day average
Volume: a spike above the 20-day average
Volume: a spike above the 20-day average
Overnight gap: a gap up from the prior close
Free with a Finzer account.
Profile
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- Not reported
- CUSIP
- Not reported
Company
- Employees
- 2,292
- Headquarters
- Bubendorf, United Kingdom
- Website
- https://www.bachem.com
Market
- Shares outstanding
- 13.6M
- Market cap
- £5.57B
Key dates
- Next earnings
- Mar 4, 2027
Highlights
- Market cap
- £5.57B
- EPS LTM
- CHF 1.97
- P/E LTM
- 46.32
- Div yield
- 1.23%
Fundamentals (LTM)
- Revenue
- CHF 805.08M+61.35%up year on year
- Net income
- CHF 147.78M+50.53%up year on year
- Gross margin
- 29.63%-6.09%down year on year
- Free cash flow
- -CHF 91.19M-104.09%down year on year
Latest news
News is not sourced for this exchange.
Business summary
Bachem Holding AG is listed on London Stock Exchange (United Kingdom) under the ticker 0QND. Its market capitalisation is £5.57B, from 13.6M shares outstanding, as of . Across the 248 trading sessions to the shares traded between £48.70 and £84.00, and the last close of £81.35 sits 92% of the way up that range. The company is headquartered in Bubendorf, United Kingdom, and employs about 2,292 people. This is the London Stock Exchange listing of Bachem Holding AG; its primary listing is BANB on SIX Swiss Exchange.
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland.